====== Trandolapril ====== Trandolapril is a long-acting ACE inhibitor used in hypertension and post–myocardial infarction patients with left ventricular dysfunction. It has strong outcome data in post-MI populations. Class: → [[cardio:raas:acei|ACE Inhibitors]] ---- ===== Mechanism of Action ===== • Inhibits Angiotensin-Converting Enzyme (ACE) • ↓ Angiotensin II • ↓ Aldosterone • ↑ Bradykinin Net Effects: • ↓ Systemic vascular resistance (afterload) • Mild ↓ preload • ↓ Ventricular remodeling • ↓ Blood pressure Mechanism identical to other ACE inhibitors. ---- ===== Unique Features ===== • Prodrug → converted to active trandolaprilat • Long-acting (once-daily dosing) • Strong evidence in post-MI LV dysfunction (TRACE trial) Less commonly prescribed today but pharmacologically solid. ---- ===== Indications ===== ==== Hypertension ==== • Effective once-daily ACE inhibitor → [[cardio:hypertension:start|Hypertension Module]] ---- ==== Post-Myocardial Infarction with LV Dysfunction ==== • Reduces mortality • Prevents ventricular remodeling TRACE trial demonstrated survival benefit in patients with reduced EF after MI. ---- ==== Heart Failure (HFrEF) ==== • Used similarly to other ACE inhibitors • Mortality benefit expected as class effect → [[cardio:heart_failure:start|Heart Failure Module]] ---- ===== Dosing ===== Hypertension: • Start: 1 mg once daily • Typical range: 1–4 mg once daily • Max: 4 mg daily Post-MI: • Start low • Titrate as tolerated Once-daily dosing. ---- ===== Pharmacokinetics ===== • Prodrug → activated in liver • Renally cleared • Long half-life of active metabolite (~16–24 hours) Dose adjustment required in renal impairment. ---- ===== Adverse Effects ===== Class Effects: • Dry cough • Hyperkalemia • Hypotension • Angioedema (rare) • Mild creatinine elevation No major differences from other ACE inhibitors. ---- ===== Monitoring ===== Monitor: • Serum creatinine • Potassium Check labs 1–2 weeks after initiation or dose changes. ---- ===== Contraindications ===== • Pregnancy • History of ACE inhibitor–induced angioedema • Bilateral renal artery stenosis ---- ===== Clinical Pearls ===== ✔ Long-acting ACE inhibitor ✔ Strong post-MI LV dysfunction data (TRACE) ✔ Once-daily dosing ✔ Less commonly prescribed today but evidence-based ✔ Same monitoring as all ACE inhibitors ---- Related: → [[cardio:raas:acei|ACE Inhibitors]] → [[cardio:raas:ramipril|Ramipril]] → [[cardio:heart_failure:start|Heart Failure Module]] → [[cardio:start|Return to CV Modules]]